These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HIV antibodies in intravenous drug abusers. Wodak A; Gold J Med J Aust; 1986 Sep; 145(6):298. PubMed ID: 3018463 [No Abstract] [Full Text] [Related]
3. AIDS case dismissed on legal technicality. Barnes DM Science; 1986 Jul; 233(4762):414. PubMed ID: 3014655 [No Abstract] [Full Text] [Related]
4. Strategies for an AIDS vaccine. Barnes DM Science; 1986 Sep; 233(4769):1149-53. PubMed ID: 3016904 [No Abstract] [Full Text] [Related]
5. [Pathogenic retrovirus--current facts and hypotheses]. Kazimierska E Pol Tyg Lek; 1986 Jan; 41(3):86-7. PubMed ID: 3010262 [No Abstract] [Full Text] [Related]
6. Unusual serological profiles in AIDS. Marlink R; Allan J; Essex M Lancet; 1986 Jun; 1(8494):1389. PubMed ID: 2872505 [No Abstract] [Full Text] [Related]
7. HTLV-III antibody testing in Spain. Nájera R; Echevarría JM; Varela JM; de Andrés R; de la Loma A Lancet; 1985 Oct; 2(8458):783. PubMed ID: 2864517 [No Abstract] [Full Text] [Related]
8. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. Kiprov DD; Anderson RE; Morand PR; Simpson DM; Chermann JC; Levy JA; Ross AR N Engl J Med; 1985 Jun; 312(23):1517. PubMed ID: 2985997 [No Abstract] [Full Text] [Related]
9. AIDS: the significance of anti-HTLV-III antibodies. Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098 [No Abstract] [Full Text] [Related]
10. [Specific antibodies against human T cell leukemia virus found in AIDS patients]. Nagy K; Clapham P; Weiss R; Földes I Orv Hetil; 1984 Jun; 125(26):1557-60. PubMed ID: 6330642 [No Abstract] [Full Text] [Related]
11. [Seroepidemiology of the HTLV-III virus in a high-risk Panamanian population. Preliminary report]. Arosemena JR; Cuevas M; Ulloa E; Guerrero DM; Gómez B; Cantón-Dutary A; Reyes R; Quiroz E; de Britton RM; Brenes MM Rev Med Panama; 1986 May; 11(2):124-33. PubMed ID: 3018847 [No Abstract] [Full Text] [Related]
12. [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells]. Harada S; Yamamoto N Tanpakushitsu Kakusan Koso; 1985 Dec; 30(13):1394-407. PubMed ID: 3003812 [No Abstract] [Full Text] [Related]
13. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Lasky LA; Groopman JE; Fennie CW; Benz PM; Capon DJ; Dowbenko DJ; Nakamura GR; Nunes WM; Renz ME; Berman PW Science; 1986 Jul; 233(4760):209-12. PubMed ID: 3014647 [TBL] [Abstract][Full Text] [Related]
14. Prevention of HIV infection. Hopkins DR JAMA; 1987 Feb; 257(8):1046-7. PubMed ID: 3027424 [No Abstract] [Full Text] [Related]
16. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638 [No Abstract] [Full Text] [Related]
17. Testing for HTLV-III/LAV antibody. Holston JL Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171 [No Abstract] [Full Text] [Related]
18. Unconventional vaccines: immunization with anti-idiotype antibody against viral diseases. Koprowski H Cancer Res; 1985 Sep; 45(9 Suppl):4689s-4690s. PubMed ID: 2990707 [No Abstract] [Full Text] [Related]